The Wesley Hospital, Brisbane, Queensland, Australia.
Wesley Medical Research, Brisbane, Queensland, Australia.
BJU Int. 2021 Jan;127(1):71-79. doi: 10.1111/bju.15134. Epub 2020 Sep 7.
OBJECTIVE: To evaluate the ability of preoperative multiparametric magnetic resonance imaging (mpMRI) and a gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography ( Ga-PSMA PET/CT) scan to predict pathological outcomes and also identify a group of men with a <5% risk of histological pelvic lymph node metastasis (LNM) at pelvic lymph node dissection (PLND) performed during a robot-assisted laparoscopic radical prostatectomy (RALP) for prostate cancer. We then aimed to compare these results to known risk calculators for LNM, including the Cancer of the Prostate Risk Assessment (CAPRA) score, Memorial Sloan Kettering Cancer Centre (MSKCC) and Briganti nomograms. PATIENTS AND METHODS: Between July 2014 and September 2019 only men who had both a preoperative mpMRI and staging Ga-PSMA PET/CT at our institution followed by a RALP with PLND referred to a single specialist uropathology laboratory were considered for inclusion. The data were collected retrospectively prior to February 2019 and in a prospective manner thereafter. A model was built to allocate probabilities of the men with a negative Ga-PSMA PET/CT scan having a <5% risk of histologically LNM at RALP based on the preoperative radiological staging. RESULTS: A total of 233 consecutive men met the inclusion criteria of which 58 men (24.9%) had a LNM identified on PLND histology. The median (range) International Society of Urological Pathology (ISUP) Grade was 5 (1-5) and the median (range) prostate-specific antigen level was 7.4 (1.5-72) ng/mL. The median (range) number of resected lymph nodes was 16 (1-53) and the median (range) number of positive nodes identified on histology was 2 (1-22). Seminal vesicle invasion on mpMRI was more common in node-positive men than in the absence of LNM (31% vs 12%). The maximum standardised uptake value of the primary tumour on Ga-PSMA PET/CT was higher in men with LNM (median 9.2 vs 7.2, P = 0.02). Suspected LNM were identified in 42/233 (18.0%) men with Ga-PSMA PET/CT compared with 22/233 (9.4%) men with mpMRI (P = 0.023). The positive and negative predictive value for Ga-PSMA PET/CT was 66.7% and 84.3% respectively, compared to 59.1% and 78.7% for mpMRI. A predictive model showed only two men (4.2%) with a negative preoperative Ga-PSMA PET/CT would be positive for a histological LNM if they are ISUP Grade < 5 and Prostate Imaging-Reporting and Data System (PI-RADS) <5; or ISUP Grade 5 with PI-RADS < 4. An inspection of three additional variables: CAPRA score, MSKCC and Briganti nomograms did not improve the predictive probability for this group. However, of the 61 men with ISUP Grade 4-5 malignancy and also a PI-RADS 5 mpMRI, 20 (32.8%) men had a microscopic LNM despite a negative preoperative Ga-PSMA PET/CT. CONCLUSION: Preoperative Ga-PSMA/PET CT was more sensitive in identifying histological pelvic LNM than 3-T mpMRI. Men with a negative Ga-PSMA PET/CT have a lower risk of LNM than predicted with CAPRA scores or MSKCC and Briganti nomograms. We identified that the combination of a negative preoperative Ga-PSMA PET/CT, ISUP biopsy Grade <5 and PI-RADS <5 prostate mpMRI, or an ISUP Grade 5 with PI-RADS <4 on mpMRI was associated with a <5% risk of a LNM. The addition of CAPRA scores, MSKCC and Briganti nomograms did not improve the predictive probability within this model. Conversely, men with ISUP Grade 4-5 malignancy associated with a PI-RADS 5 prostate mpMRI had a >30% risk of microscopic LNM despite a negative preoperative Ga-PSMA PET/CT and this high-risk group would appear suitable for an extended PLND at the time of a radical prostatectomy.
目的:评估术前多参数磁共振成像(mpMRI)和镓-68 前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描(Ga-PSMA PET/CT)在预测病理结果方面的能力,并确定一组在机器人辅助腹腔镜前列腺根治性切除术(RALP)中进行盆腔淋巴结清扫术(PLND)时发生组织学盆腔淋巴结转移(LNM)风险<5%的男性。然后,我们旨在将这些结果与已知的 LNM 风险计算器进行比较,包括前列腺癌风险评估(CAPRA)评分、纪念斯隆凯特琳癌症中心(MSKCC)和布里甘蒂诺列线图。
患者和方法:2014 年 7 月至 2019 年 9 月期间,仅对在我院进行术前 mpMRI 和分期 Ga-PSMA PET/CT 检查,随后在单一专科泌尿病理实验室进行 RALP 并进行 PLND 的男性进行了回顾性和前瞻性研究。在 2019 年 2 月之前收集数据,此后以前瞻性方式收集数据。根据术前放射学分期,建立了一个模型,根据 Ga-PSMA PET/CT 扫描结果为阴性的男性,分配其在 RALP 中发生组织学 LNM 的可能性<5%的概率。
结果:共有 233 例连续男性符合纳入标准,其中 58 例(24.9%)在 PLND 组织学上发现 LNM。国际泌尿病理学会(ISUP)分级中位数(范围)为 5(1-5),前列腺特异性抗原水平中位数(范围)为 7.4(1.5-72)ng/ml。切除的淋巴结中位数(范围)为 16(1-53),组织学上阳性淋巴结的中位数(范围)为 2(1-22)。mpMRI 上精囊侵犯在淋巴结阳性男性中比在无 LNM 的男性中更常见(31%比 12%)。Ga-PSMA PET/CT 上原发肿瘤的最大标准化摄取值在有 LNM 的男性中较高(中位数 9.2 比 7.2,P=0.02)。与 mpMRI 相比,Ga-PSMA PET/CT 发现 42/233(18.0%)男性疑似有 LNM,而 mpMRI 发现 22/233(9.4%)男性疑似有 LNM(P=0.023)。Ga-PSMA PET/CT 的阳性和阴性预测值分别为 66.7%和 84.3%,而 mpMRI 分别为 59.1%和 78.7%。预测模型显示,如果术前 Ga-PSMA PET/CT 为阴性且 ISUP 分级<5 和前列腺成像报告和数据系统(PI-RADS)<5;或 ISUP 分级 5 且 PI-RADS<4,则仅 2 名男性(4.2%)的组织学 LNM 为阳性。检查另外三个变量:CAPRA 评分、MSKCC 和布里甘蒂诺列线图并没有提高这一组的预测概率。然而,在 61 名 ISUP 分级 4-5 恶性肿瘤且 mpMRI 分级 PI-RADS 5 的男性中,尽管术前 Ga-PSMA PET/CT 为阴性,但仍有 20 名(32.8%)男性有显微镜下 LNM。
结论:术前 Ga-PSMA/PET CT 在识别组织学盆腔 LNM 方面比 3-T mpMRI 更敏感。与 CAPRA 评分或 MSKCC 和 Briganti 列线图相比,术前 Ga-PSMA PET/CT 阴性的男性发生 LNM 的风险较低。我们发现,术前 Ga-PSMA PET/CT 阴性,ISUP 活检分级<5 和 PI-RADS<5 前列腺 mpMRI,或 ISUP 分级 5 且 PI-RADS<4 的前列腺 mpMRI 与 LNM 风险<5%相关。在该模型中,添加 CAPRA 评分、MSKCC 和 Briganti 列线图并没有提高预测概率。相反,在 ISUP 分级 4-5 恶性肿瘤相关的 PI-RADS 5 前列腺 mpMRI 中,尽管术前 Ga-PSMA PET/CT 为阴性,但仍有>30%的男性发生显微镜下 LNM,这一高危组似乎适合在根治性前列腺切除术时进行扩展的 PLND。
Prostate Cancer Prostatic Dis. 2024-3-22